مرض التغيرات الشحيحة: العلاج عند وجود موانع لاستخدام الجلوكوكورتيكويدات

References

DOI: 10.1016/j.kint.2021.05.021

• For patients in whom glucocorticoids may be relatively contraindicated, consider initial therapy with cyclophosphamide, a CNI, or MMF.
• In patients with absolute or relative contraindication to steroids, we agree alternative immunosuppressive agents such as CNI, Cyclophosphamide, MMF or Rituximab should be considered.